Viewpoints on vessels and vanishing bones in Gorham–Stout disease
Open Access
- 1 June 2014
- journal article
- review article
- Published by Elsevier BV in Bone
- Vol. 63, 47-52
- https://doi.org/10.1016/j.bone.2014.02.011
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (T32-HL098040)
- Lymphatic Malformation Institute
- National Institutes of Health (P01-AR048564, R01-AR036819, R01-AR036820)
This publication has 81 references indexed in Scilit:
- Somatic Mosaic Activating Mutations in PIK3CA Cause CLOVES SyndromeAmerican Journal of Human Genetics, 2012
- Deciphering the roles of macrophages in developmental and inflammation stimulated lymphangiogenesisVascular Cell, 2012
- A Mosaic Activating Mutation inAKT1Associated with the Proteus SyndromeThe New England Journal of Medicine, 2011
- TNF-α promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cellsProceedings of the National Academy of Sciences of the United States of America, 2011
- Gorham–Stout Disease Affecting Both Hands: Stabilisation during Biphosphonate TreatmentHAND, 2010
- Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growthNature Medicine, 2009
- Defective remodeling and maturation of the lymphatic vasculature in Angiopoietin-2 deficient miceDevelopmental Biology, 2008
- VEGF-C, a Lymphatic Growth Factor, Is a RANKL Target Gene in Osteoclasts That Enhances Osteoclastic Bone Resorption through an Autocrine MechanismOnline Journal of Public Health Informatics, 2008
- Osteocytes, mechanosensing and Wnt signalingBone, 2008
- Platelet-derived growth factor receptor-β in Gorham's diseaseNature Clinical Practice Oncology, 2006